Nature’s Sunshine Products (NASDAQ:NATR) Price Target Raised to $23.00

Nature’s Sunshine Products (NASDAQ:NATR) had its target price increased by DA Davidson from $21.00 to $23.00 in a report published on Monday morning,Benzinga reports. DA Davidson currently has a buy rating on the stock.

Other analysts have also recently issued research reports about the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Nature’s Sunshine Products in a research note on Wednesday, October 8th. Canaccord Genuity Group lifted their target price on Nature’s Sunshine Products from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $22.50.

Nature’s Sunshine Products Price Performance

Nature’s Sunshine Products stock opened at $20.69 on Monday. The business has a 50 day moving average of $15.63 and a 200-day moving average of $15.21. The company has a market capitalization of $361.99 million, a P/E ratio of 27.96 and a beta of 1.09. Nature’s Sunshine Products has a 1 year low of $11.01 and a 1 year high of $20.72.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its earnings results on Thursday, November 6th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.18. Nature’s Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. The firm had revenue of $88.99 million for the quarter, compared to analyst estimates of $119.39 million. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.

Insiders Place Their Bets

In related news, EVP Bryant J. Yates sold 5,000 shares of the business’s stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $16.77, for a total value of $83,850.00. Following the transaction, the executive vice president owned 102,170 shares in the company, valued at $1,713,390.90. The trade was a 4.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 5.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in NATR. Mackenzie Financial Corp bought a new stake in shares of Nature’s Sunshine Products during the 1st quarter valued at about $287,000. Connor Clark & Lunn Investment Management Ltd. increased its holdings in Nature’s Sunshine Products by 80.1% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 38,602 shares of the company’s stock worth $484,000 after purchasing an additional 17,168 shares in the last quarter. Nuveen LLC acquired a new position in Nature’s Sunshine Products in the first quarter valued at approximately $437,000. Russell Investments Group Ltd. boosted its holdings in shares of Nature’s Sunshine Products by 351.2% during the 1st quarter. Russell Investments Group Ltd. now owns 12,398 shares of the company’s stock worth $156,000 after buying an additional 9,650 shares in the last quarter. Finally, Jane Street Group LLC acquired a new stake in shares of Nature’s Sunshine Products during the 1st quarter worth approximately $174,000. 79.40% of the stock is owned by institutional investors.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.